Stocks To Watch For May 30, 2014 - Microsoft (NASDAQ:MSFT)

Zynga Inc ZNGA There are some signs of a possible bounce at this point due to oversold indicators and some positive divergences, which often leads to short covering. Let's see whether the stock can gather enough momentum to break through $3.56 (20EMA).

Shares of Microsoft Corporation MSFT are starting to heat up again and are worth watching. If volume can pick up I believe this stock can break through resistance at $40.5 and re-test its recent highs around $41.37.

Shares of Oracle Corporation ORCL have been slowly gaining some traction amid light buying pressure the last few days. A break through the $42.35 level could accelerate it higher.

Shares of Generex Biotechnology Corporation GNBT closed the day gaining more than five percentage points on solid volume. The stock has been on a down trend since it reached 52 weeks high of $.056 in January. Its technical chart show some bullish signals as KD is now going up and the MACD just crossed above the signal line. With this daily chart bull signal its very possible that we could see a continuation into tomorrow. The company announced last month that two abstracts in respect of results of the on-going Phase II study of a novel cancer vaccine designed to prevent relapse in patients who have had breast cancer will be presented at ASCO that will start tomorrow. The ASCO Meeting is the premier annual oncology symposium, bringing together more than 25,000 oncology professionals from a broad range of specialties. This penny stock should be on your radar tomorrow.

During the day I tweet many times to my readers. I encourage everybody to subscribe AC Investor Blog twitter and newsletter, so you can receive my trade ideas and stock news in real time.

Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Market News and Data brought to you by Benzinga APIs